FTC Issues Policy Statement on Patent Listing | Dechert LLP

The FTC is focusing its attention on the listing of pharmaceutical patents in the FDA’s Orange Book. Patent listing may be the subject of FTC inquiry even absent...

Related Keywords

Martin Shkreli , Drug Administration , Amicus Brief In Jazz Pharmaceuticals Inc , Orange Book , Federal Trade Commission , Policy Statement , Hatch Waxman Act , New Drug Application , Drug Products , Therapeutic Equivalence Evaluations , Abbreviated New Drug Application , Orange Book Listed , Sherman Act , Amicus Brief , Jazz Pharmaceuticals Inc , Orange Book Questions , Answers Guidance , Book Policy Statement , Book Policy Statementat , Policy Statement Regarding , Unfair Methods , Competition Under Section , Federal Trade Commission Act , Amicus Curiae ,